Complementary research, resources, policies improve outcomes for those with substance use disorders: Panel
by Jill Clendening
Researchers recommend ways to measure ‘spillover effects’ on families, caregivers
Imagine the unthinkable: A child diagnosed with cancer who suddenly needs extensive treatment and care for a lengthy period. Researchers have long studied the economic value of that care (e.g., outcomes relative to cost) but measuring the impact of patient illness on parents or caregivers has been underestimated and inconsistently incorporated into economic evaluations.
Hospital readmissions tied to supply of care options in communities around hospitals
A new study in Health Affairs from researchers at Vanderbilt Univer
Filling multiple opioid prescriptions after childbirth is associated with a 50% increase in the risk of maternal death
In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.
New study in NEJM illustrates how much it would cost for cancer drugs covered under Medicare Part D
A new study in the New England Journal of Medicine highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.
Vanderbilt MPH Program Events for National Public Health Week 2022
Faces of Public Health
Numerous careers can fall under the umbrella of Public Health. Come and listen to esteemed MPH alumni as they give advice on navigating the career landscape, discuss how their jobs fit into Public Health, and more! This panel discussion will dive deep into the many faces of Public Health!
Study: More than 75% of Davidson Co. women diagnosed with invasive cervical cancer between 2008-18 had not received appropriate screening
A new study of more than 200 Davidson County women diagnosed with invasive cervical cancer between 2008 and 2018 by Vanderbilt University Medical Center researchers found that 77% of those women did not receive recommended screening or follow-up before their diagnosis.
